Heart attack gene therapy study halted before it began
NCT ID NCT03404024
First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 29 times
Summary
This study aimed to test a new gene therapy called VM202RY, injected directly into the heart, to see if it could safely improve heart function in people who recently had a heart attack. The study was planned for adults aged 19 to 75 with reduced heart pumping ability. However, the study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Chonnam National University Hospital
Gwangju, South Korea
-
Ewha Womans University Medical Center
Seoul, South Korea
-
GangNeung Asan Hospital
Gangneung, South Korea
-
KyungHee University Medical Center
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.